Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA518889
Max Phase: Preclinical
Molecular Formula: C21H29N5O3
Molecular Weight: 399.50
Molecule Type: Small molecule
Associated Items:
ID: ALA518889
Max Phase: Preclinical
Molecular Formula: C21H29N5O3
Molecular Weight: 399.50
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccc2c(c1)/C(=N/N1CC(=O)N(CCCN3CCN(C)CC3)C1=O)CCO2
Standard InChI: InChI=1S/C21H29N5O3/c1-16-4-5-19-17(14-16)18(6-13-29-19)22-26-15-20(27)25(21(26)28)8-3-7-24-11-9-23(2)10-12-24/h4-5,14H,3,6-13,15H2,1-2H3/b22-18+
Standard InChI Key: PERQXAHKPJQDGS-RELWKKBWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 399.50 | Molecular Weight (Monoisotopic): 399.2270 | AlogP: 1.38 | #Rotatable Bonds: 5 |
Polar Surface Area: 68.69 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.95 | CX Basic pKa: 7.98 | CX LogP: 0.98 | CX LogD: 0.30 |
Aromatic Rings: 1 | Heavy Atoms: 29 | QED Weighted: 0.70 | Np Likeness Score: -1.01 |
1. Du L, Li M, Yang Q, Tang Y, You Q, Xia L.. (2009) Molecular hybridization, synthesis, and biological evaluation of novel chroman I(Kr) and I(Ks) dual blockers., 19 (5): [PMID:19185489] [10.1016/j.bmcl.2009.01.022] |
Source(1):